Leonardo Flenghi

ALK+ lymphoma: clinico-pathological findings and outcome.

Brunangelo Falini, Stefano Pileri, Pier Luigi Zinzani et al. · PubMed · 1999 · 567 citations

Medicine, Oncology, Pathology +12

CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy

Brunangelo Falini, Stefano Pileri, Giovanni Pizzolo et al. · Blood · 1995 · 444 citations · Full text

Life Sciences, Cancer Biology, Immunology +11

PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.

Brunangelo Falini, Leonardo Flenghi, Stefano Pileri et al. · PubMed · 1993 · 301 citations

Life Sciences, Cell Biology, Immunology +13

ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum

Brunangelo Falini, Barbara Bigerna, Marco Fizzotti et al. · American Journal Of Pathology · 1998 · 275 citations · Full text

Veterinary Medicine, Oncology, Pathology +16

Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin

Brunangelo Falini, Leonardo Flenghi, Franco Aversa et al. · The Lancet · 1992 · 215 citations

Life Sciences, Immunology, Pharmacotherapy +13